Clinical Trial

Helical Tomotherapy in Multiple Myeloma

Recruiting
View on ClinicalTrials.gov →
Summary
To explore the safety and efficacy of systemic radiotherapy (TBI) combined with melphalan (Mel) for pretreatment of autologous hematopoietic stem cells in multiple myeloma.
Trial Details
NCT Number NCT05970198
Lead Sponsor Fuling Zhou
Conditions Multiple Myeloma
Enrollment 58 participants
Start Date 2023-06-14
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-08-01